Literature DB >> 12009389

Association of umbilical placental vascular disease with fetal acute inflammatory cytokine responses.

Brian Trudinger1, Jun Wang, Neil Athayde, Lucinda Beutler, Xin Wang.   

Abstract

OBJECTIVE: We examined the hypothesis that fetal proinflammatory cytokine release is a feature of placental vascular disease causing fetal compromise. We measured the concentrations of fetal proinflammatory cytokines interleukin 6 (IL-6), tumor necrosis factor alpha (TNF-alpha), and interleukin-8 (IL-8) in the presence of vascular disease in the umbilical placental villous circulation. Vascular disease was identified by high-resistance umbilical artery Doppler flow velocity waveform studies.
METHODS: We measured levels of the inflammatory cytokines IL-6 and TNF-alpha and the chemokine IL-8 in fetal blood. Blood was collected from the umbilical vein at delivery, and serum was stored at -70C until assayed using chemiluminescent and enzyme-linked immunosorbent assay methods. We studied 36 normal pregnancies delivered by elective cesarean at term and 50 pregnancies with a high-resistance umbilical artery Doppler flow velocity waveform pattern indicative of fetal placental vascular disease delivered by elective cesarean because of potential fetal compromise.
RESULTS: In the presence of umbilical placental vascular disease there were significantly higher levels of IL-6 (median 5.3 pg/mL, P <.05) and IL-8 (median 26.5 pg/mL, P <.01) compared with normal pregnancies (median value of IL-6 and IL-8 were below assay threshold). There was no difference for TNF-alpha, with the median results undetectable in both groups.
CONCLUSION: We found higher concentrations of IL-6 and IL-8 in the fetal circulation in the presence of umbilical placental vascular disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12009389

Source DB:  PubMed          Journal:  J Soc Gynecol Investig        ISSN: 1071-5576


  1 in total

1.  Potential role of Toll-like receptors in programming of vascular dysfunction.

Authors:  Jennifer A Thompson; R Clinton Webb
Journal:  Clin Sci (Lond)       Date:  2013-03-13       Impact factor: 6.124

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.